Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: Correlation with proliferation

作者: Lydia Nakopoulou , Kalliopi Stefanaki , Effie Panayotopoulou , Ioanna Giannopoulou , Pauline Athanassiadou

DOI: 10.1053/HUPA.2002.126879

关键词:

摘要: Vascular endothelial growth factor (VEGF) and its receptor Flk-1/KDR play an important role in vascular permeability tumor angiogenesis. Prompted by the hypothesis that VEGF/Flk-1 system may have regulatory roles breast carcinogenesis, we investigated expression of Flk-1 141 invasive carcinomas correlation with clinical immunohistochemical prognostic parameters, including proliferation indices like Ki-67 Topoisomerase IIalpha (Topo-IIalpha). The avidin-biotin-peroxidase method was performed on paraffin sections for detection Flk-1, p53, Bcl-2, c-erbB-2, Ki-67, Topo-IIalpha, ER, PR. detected 91 (64.5%) showing a widespread cytoplasmic most neoplastic cells. correlated menopausal status (P = 0.051) patient nuclear grade carcinoma 0.003), but demonstrated no histologic grade, stage, survival. It is interesting significant 2 well-established indices, 0.037) topo-IIalpha 0.009), whereas there PR, c-erbB-2. Moreover, showed inverse TIMP-1 mRNA localization intratumoral stromal cells 0.013). In conclusion, suggests VEGF exert activity mammary cancer through Flk-1. On other hand, supports notion inhibitory

参考文章(57)
P. Bausero, M.-H. Ben-Mahdi, J.-P. Mazucatelli, C. Bloy, M. Perrot-Applanat, Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia American Journal of Physiology-heart and Circulatory Physiology. ,vol. 279, ,(2000) , 10.1152/AJPHEART.2000.279.5.H2033
U P Thorgeirsson, D F Alonso, D E Gomez, H Yoshiji, Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. European Journal of Cell Biology. ,vol. 74, pp. 111- 122 ,(1997)
H. F. Dvorak, J. A. Nagy, D. Feng, L. F. Brown, A. M. Dvorak, Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Current Topics in Microbiology and Immunology. ,vol. 237, pp. 97- 132 ,(1999) , 10.1007/978-3-642-59953-8_6
Susan Fuggle, Roy Bicknell, David Cranston, Tim O'Brien, Adrian L. Harris, Different Angiogenic Pathways Characterize Superficial and Invasive Bladder Cancer Cancer Research. ,vol. 55, pp. 510- 513 ,(1995)
Bronislaw Pytowski, William O’Connor, Daniel J. Hicklin, Andrea Hooper, Yiwen Li, Karen King, Angel Santiago, Peter Bohlen, James Huber, Jay Overholser, Larry Witte, Marie Prewett, Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Several Mouse and Human Tumors Cancer Research. ,vol. 59, pp. 5209- 5218 ,(1999)
Masabumi Shibuya, Role of Vegf-Flt Receptor System in Normal and Tumor Angiogenesis Advances in Cancer Research. ,vol. 67, pp. 281- 316 ,(1995) , 10.1016/S0065-230X(08)60716-2
Eleanor J. Manseau, Brygida Berse, Kathi Tognazzi, Donald R. Senger, Lawrence F. Brown, Harold F. Dvorak, Robert W. Jackman, Expression of Vascular Permeability Factor (Vascular Endothelial Growth Factor) and Its Receptors in Adenocarcinomas of the Gastrointestinal Tract Cancer Research. ,vol. 53, pp. 4727- 4735 ,(1993)
W. Gregory Roberts, Joan Delaat, Motoo Nagane, Su Huang, Webster K. Cavenee, George E. Palade, Host Microvasculature Influence on Tumor Vascular Morphology and Endothelial Gene Expression The American Journal of Pathology. ,vol. 153, pp. 1239- 1248 ,(1998) , 10.1016/S0002-9440(10)65668-4